Clinical Trial Update: Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of testosterone replacement in men with non-metastatic castration-resistant prostate cancer was terminated, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• TESTOSTERONE (testosterone)

Snippet

Sponsor: University of Chicago | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-06-11